Business Standard

Thursday, December 19, 2024 | 05:51 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Regulators halt eye products' production at Global Pharma Healthcare site

Firm under US FDA scanner for bacterial contamination of its eye drops

Global Pharma Healthcare
Premium

Photo: Website

Sohini Das Mumbai
Chennai-based Global Pharma Healthcare, which has been under the scanner of the US FDA for potential bacterial contamination of its eye-drops, has been asked to stop production of its ophthalmic range of products at its site.

A joint team of officials from the Central Drugs Standard Control Organisation (CDSCO) and State Drug Controller inspected the site on Friday.

In the joint investigation report (Business Standard has a copy of the report) the drug inspector CDSCO South Zone C Manivillavan and Deepa Joseph, senior drugs inspector, Kancheepuram zone, Director of Drugs Control, Tamil Nadu have noted that the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in